261 related articles for article (PubMed ID: 21335079)
1. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B
Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079
[TBL] [Abstract][Full Text] [Related]
2. Thermochemical and spectroscopic studies on the supramolecular complex of PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
Buczkowski A; Urbaniak P; Palecz B
Int J Pharm; 2012 May; 428(1-2):178-82. PubMed ID: 22429888
[TBL] [Abstract][Full Text] [Related]
3. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.
Buczkowski A; Waliszewski D; Urbaniak P; Palecz B
Int J Pharm; 2016 May; 505(1-2):1-13. PubMed ID: 27039147
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic and calorimetric studies on the interaction between PAMAM G4-OH and 5-fluorouracil in aqueous solutions.
Buczkowski A; Urbaniak P; Piekarski H; Palecz B
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():401-405. PubMed ID: 27569773
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic and calorimetric studies of formation of the supramolecular complexes of PAMAM G5-NH₂ and G5-OH dendrimers with 5-fluorouracil in aqueous solution.
Buczkowski A; Olesinski T; Zbicinska E; Urbaniak P; Palecz B
Int J Pharm; 2015 Jul; 490(1-2):102-11. PubMed ID: 25997661
[TBL] [Abstract][Full Text] [Related]
6. A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting.
Jin Y; Ren X; Wang W; Ke L; Ning E; Du L; Bradshaw J
Int J Pharm; 2011 Nov; 420(2):378-84. PubMed ID: 21925254
[TBL] [Abstract][Full Text] [Related]
7. Formation of complexes between PAMAM-NH2 G4 dendrimer and L-α-tryptophan and L-α-tyrosine in water.
Buczkowski A; Urbaniak P; Belica S; Sekowski S; Bryszewska M; Palecz B
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jul; 128():647-52. PubMed ID: 24704481
[TBL] [Abstract][Full Text] [Related]
8. Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.
Prieto MJ; Temprana CF; del Río Zabala NE; Marotta CH; Alonso Sdel V
Eur J Med Chem; 2011 Mar; 46(3):845-50. PubMed ID: 21251731
[TBL] [Abstract][Full Text] [Related]
9. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
Jain V; Maiti PK; Bharatam PV
J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
[TBL] [Abstract][Full Text] [Related]
10. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
11. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
[TBL] [Abstract][Full Text] [Related]
12. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil.
Venuganti VV; Perumal OP
Int J Pharm; 2008 Sep; 361(1-2):230-8. PubMed ID: 18582550
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
14. Complexes of dendrimers with bovine serum albumin.
Mandeville JS; Tajmir-Riahi HA
Biomacromolecules; 2010 Feb; 11(2):465-72. PubMed ID: 20085247
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of novel physically cross-linked hydrogels composed of poly(vinyl alcohol) and amine-terminated polyamidoamine dendrimer.
Wu XY; Huang SW; Zhang JT; Zhuo RX
Macromol Biosci; 2004 Feb; 4(2):71-5. PubMed ID: 15468196
[TBL] [Abstract][Full Text] [Related]
16. Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms.
Giri J; Diallo MS; Simpson AJ; Liu Y; Goddard WA; Kumar R; Woods GC
ACS Nano; 2011 May; 5(5):3456-68. PubMed ID: 21438566
[TBL] [Abstract][Full Text] [Related]
17. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive properties of poly(amidoamine) dendrimers with peripheral phenylalanine residues.
Tono Y; Kojima C; Haba Y; Takahashi T; Harada A; Yagi S; Kono K
Langmuir; 2006 May; 22(11):4920-2. PubMed ID: 16700575
[TBL] [Abstract][Full Text] [Related]
19. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.
Ouyang L; Ma L; Jiang B; Li Y; He D; Guo L
Eur J Med Chem; 2010 Jun; 45(6):2705-11. PubMed ID: 20171762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
